TwinBeech Capital’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$200K Buy
+5,059
New +$181K 0.05% 357
2023
Q3
– Sell
-360,843
Closed -$2.72M – 891
2023
Q2
$2.72M Buy
+360,843
New +$2.93M 0.05% 347

Other funds holding TEVA

TwinBeech Capital's TEVA Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Teva Pharmaceutical Industries (TEVA) in Q3 2026: 5,059 shares worth $200K. The stake represents 0.05% of the portfolio and ranks #357 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in TEVA as recently as Q2 2023.

TwinBeech Capital first reported a position in TEVA in Q2 2023 and has held it in 2 quarters since. The position peaked at $2.72M in Q2 2023. 595 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • TwinBeech Capital held 5,059 shares of Teva Pharmaceutical Industries worth $200K as of Q3 2026.
  • Teva Pharmaceutical Industries was a new TwinBeech Capital position in Q3 2026.
  • Teva Pharmaceutical Industries made up 0.05% of TwinBeech Capital's portfolio in Q3 2026, its #357 holding.
  • TwinBeech Capital first reported a position in Teva Pharmaceutical Industries in Q2 2023 and has held it in 2 quarters since.
  • TwinBeech Capital's Teva Pharmaceutical Industries position peaked at $2.72M in Q2 2023.
  • 595 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.